OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
Raymond Hutubessy, Jeremy A. Lauer, Birgitte Giersing, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Raymond Hutubessy, Jeremy A. Lauer, Birgitte Giersing, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Showing 26-50 of 44 citing articles:
The need and ongoing efforts to understand the full value of improved influenza vaccines
Joseph S. Bresee, Mitsuki Koh, Christopher Chadwick, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7044-7046
Closed Access | Times Cited: 6
Joseph S. Bresee, Mitsuki Koh, Christopher Chadwick, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7044-7046
Closed Access | Times Cited: 6
Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide
Joy E. Lawn, Jaya Chandna, Proma Paul, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. Supplement_1, pp. S1-S4
Open Access | Times Cited: 13
Joy E. Lawn, Jaya Chandna, Proma Paul, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. Supplement_1, pp. S1-S4
Open Access | Times Cited: 13
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines
William P. Hausdorff, Jessica Price, Frédéric Debellut, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 149-149
Open Access | Times Cited: 8
William P. Hausdorff, Jessica Price, Frédéric Debellut, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 149-149
Open Access | Times Cited: 8
New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement
Philip O. Buck, Aparna Gomes, Ekkehard Beck, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 234-234
Open Access | Times Cited: 1
Philip O. Buck, Aparna Gomes, Ekkehard Beck, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 234-234
Open Access | Times Cited: 1
Health and economic impacts of Lassa vaccination campaigns in West Africa
David R. Smith, Joanne Turner, Patrick Fahr, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
David R. Smith, Joanne Turner, Patrick Fahr, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment
Frederick McElwee, Anthony T. Newall
PharmacoEconomics (2024) Vol. 42, Iss. S2, pp. 187-197
Open Access | Times Cited: 1
Frederick McElwee, Anthony T. Newall
PharmacoEconomics (2024) Vol. 42, Iss. S2, pp. 187-197
Open Access | Times Cited: 1
A Structured Narrative Literature Review of the Broader Value of Adult Immunisation Programmes
Hania El Banhawi, E. J. Bell, Margherita Neri, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 852-852
Open Access | Times Cited: 1
Hania El Banhawi, E. J. Bell, Margherita Neri, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 852-852
Open Access | Times Cited: 1
Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand: a modelling study
Simon R. Procter, Naomi R. Waterlow, Sreejith Radhakrishnan, et al.
BMJ Global Health (2024) Vol. 9, Iss. 11, pp. e015837-e015837
Open Access | Times Cited: 1
Simon R. Procter, Naomi R. Waterlow, Sreejith Radhakrishnan, et al.
BMJ Global Health (2024) Vol. 9, Iss. 11, pp. e015837-e015837
Open Access | Times Cited: 1
National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study
Jessica Price, Jessica Mooney, Carolyn Bain, et al.
Vaccine (2021) Vol. 40, Iss. 2, pp. 370-379
Open Access | Times Cited: 8
Jessica Price, Jessica Mooney, Carolyn Bain, et al.
Vaccine (2021) Vol. 40, Iss. 2, pp. 370-379
Open Access | Times Cited: 8
Vaccine Value Profiles
Birgitte Giersing, Ruth A. Karron, Marta Tufet Bayona, et al.
Vaccine (2023) Vol. 41, pp. S1-S2
Open Access | Times Cited: 3
Birgitte Giersing, Ruth A. Karron, Marta Tufet Bayona, et al.
Vaccine (2023) Vol. 41, pp. S1-S2
Open Access | Times Cited: 3
A Strep A vaccine global demand and return on investment forecast to inform industry research and development prioritization
Donald R. Walkinshaw, Meghan E. E. Wright, Marni Williams, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Donald R. Walkinshaw, Meghan E. E. Wright, Marni Williams, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries
Jessica Mooney, Jessica Price, Carolyn Bain, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270369-e0270369
Open Access | Times Cited: 3
Jessica Mooney, Jessica Price, Carolyn Bain, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270369-e0270369
Open Access | Times Cited: 3
Long-term healthcare utilisation, costs and quality of life after invasive group BStreptococcusdisease: a cohort study in five low-income and middle-income countries
Farah Seedat, Simon R. Procter, Ziyaad Dangor, et al.
BMJ Global Health (2024) Vol. 9, Iss. 5, pp. e014367-e014367
Open Access
Farah Seedat, Simon R. Procter, Ziyaad Dangor, et al.
BMJ Global Health (2024) Vol. 9, Iss. 5, pp. e014367-e014367
Open Access
Antiscience, Vaccine Hesitancy, and Pandemic Responses: Highlights from the Asia Pacific Summit on Infectious Diseases and Immunization
A Seth, Nick Sevdalis, Zulkifli Ismail, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1336-1336
Open Access
A Seth, Nick Sevdalis, Zulkifli Ismail, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1336-1336
Open Access
The Full Value of Vaccine Assessments Concept—Current Opportunities and Recommendations
Richard G. White, Nicolas A. Menzies, Allison Portnoy, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 435-435
Open Access
Richard G. White, Nicolas A. Menzies, Allison Portnoy, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 435-435
Open Access
Do current economic evaluations fully capture vaccine value: a review of evidence from India.
Navneet Kaur, Joseph L Mathew, Madhu Gupta, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-12
Closed Access
Navneet Kaur, Joseph L Mathew, Madhu Gupta, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-12
Closed Access
Economic evaluations of immunization programs as an indispensable tool for policymakers
Saskia den Boon, Sayem Ahmed, Abdur Razzaque Sarker
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Saskia den Boon, Sayem Ahmed, Abdur Razzaque Sarker
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Improving Middle-Income Countries Access to Vaccines. A Blueprint to Overcome Current Challenges
Carlos Espinal, Francisco Becerra-Posada, Jaime R. Torres
Annals of Global Health (2023) Vol. 89, Iss. 1
Open Access | Times Cited: 1
Carlos Espinal, Francisco Becerra-Posada, Jaime R. Torres
Annals of Global Health (2023) Vol. 89, Iss. 1
Open Access | Times Cited: 1
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
Naomi R. Waterlow, Simon R. Procter, Rosalind M. Eggo, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access
Naomi R. Waterlow, Simon R. Procter, Rosalind M. Eggo, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access
